Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precancerous Conditions 3Breast Neoplasms 3Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Melanoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Desmoid Tumors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Morphine 6Analgesia 6nabiximols 3Pregabalin 3Oxycodone 3Fentanyl 3ziconotide 2Surveys and Questionnaires 2Saline Solution 2Radiofrequency Ablation 2Methadone 2Lidocaine 2Ketamine 2Ibandronic Acid 2Gemcitabine 2Duloxetine Hydrochloride 2Docetaxel 2Botulinum Toxins, Type A 2trimebutine 3-thiocarbamoylbenzenesulfonate 1tanezumab 1tandutinib 1siltuximab 1resiniferatoxin 1incobotulinumtoxinA 1imisopasem manganese 1fulranumab 1erenumab 1cyclobenzaprine 1caffeine, sodium benzoate drug combination 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pain × Sulindac × Clear all
NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡